Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05296525
Title Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gamida Cell ltd
Indications

diffuse large B-cell lymphoma

follicular lymphoma

B-cell lymphoma

Therapies

GDA-201

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.